Gabapentin for Treating Acquired Neurogenic Stuttering
Gerald A. Maguire, Aislinn A Bird
Abstract
Gerald A. Maguire, Aislinn A Bird
Abstract
TO THE EDITOR: A cquired neurogenic stuttering is a dysfluency in the time patterning of speech, which occurs after a period of normal speech fluency and is caused by damage to the CNS. This differs from childhood onset fluency disorder—developmental stuttering—which presents in early childhood and is not caused by a neurologic insult. Neurogenic stuttering has been associated with injury to all areas of the brain—except the occipital lobe— and many etiologies including stroke, traumatic brain injury, seizure disorder, encephalitis, Parkinson’s disease, and dementia. γ-aminobutyric acid (GABA) modulation also has been postulated in stuttering treatment.
OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
TO THE EDITOR: A cquired neurogenic stuttering is a dysfluency in the time patterning of speech, which occurs after a period of normal speech fluency and is caused by damage to the CNS. This differs from childhood onset fluency disorder—developmental stuttering—which presents in early childhood and is not caused by a neurologic insult. Neurogenic stuttering has been associated with injury to all areas of the brain—except the occipital lobe— and many etiologies including stroke, traumatic brain injury, seizure disorder, encephalitis, Parkinson’s disease, and dementia. γ-aminobutyric acid (GABA) modulation also has been postulated in stuttering treatment.
Key concepts: Stuttering, Psychology, Fluency, Neuroscience, Neurology, Medicine, Dementia, Temporal lobe